NASDAQ:BCTX

Briacell Therapeutics Stock Forecast

etoro logo Buy BCTX
*Your capital is at risk
$2.77
+0.0300 (+1.09%)
At Close: Jun 12, 2026
AI Analysis AI Analysis of BCTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BCTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

BriaCell Therapeutics Corp. stock price ended at $2.77 on Friday, after gaining 1.09%
(Updated on Jun 12, 2026)

Sell candidate since May 14, 2026 Loss -31.60%

The BriaCell Therapeutics Corp. stock price gained 1.09% on the last trading day (Friday, 12th Jun 2026), rising from $2.74 to $2.77. During the last trading day the stock fluctuated 9.89% from a day low at $2.63 to a day high of $2.89. The price has fallen in 7 of the last 10 days and is down by -23.9% for this period. Volume fell on the last day by -228 thousand shares and in total, 191 thousand shares were bought and sold for approximately $528.54 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.72 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -25.46% during the next 3 months and, with a 90% probability hold a price between $2.03 and $2.82 at the end of this 3-month period.

BCTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 11, 2026, and so far it has risen 1.09%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BriaCell Therapeutics Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.98 and $3.64. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for BriaCell Therapeutics Corp. stock

BriaCell Therapeutics Corp. finds support from accumulated volume at $2.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.260 between high and low, or 9.89%. For the last week the stock has had daily average volatility of 8.50%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCTX) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect BriaCell Therapeutics Corp. to open at $2.76, and during the day (based on 14 day Average True Range), to move between $2.64 and $2.90, which gives a possible trading interval of +/-$0.256 (+/-9.69%) up or down from last closing price. If BriaCell Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 9.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.74 (1.08%) than the resistance at $3.02 (9.03%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BriaCell Therapeutics Corp. stock A Buy?

BriaCell Therapeutics Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.380 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $2.76 ( 0.241%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BCTX Performance

Trading levels for BCTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.02 9.15%
R2 2.92 5.56%
R1 2.86 3.34%
Price 2.77
S1 2.66 -3.83%
S2 2.60 -6.04%
S3 2.50 -9.63%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.35 20.94%
R2 3.31 19.49%
R1 3.02 9.03%
Price 2.77
S1 2.74 -1.08%
S2 0 -
S3 0 -

FAQ

What is the symbol for BriaCell Therapeutics Corp. Stock and on which exchange is it traded?
The symbol for BriaCell Therapeutics Corp. is BCTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BriaCell Therapeutics Corp. Stock?
BriaCell Therapeutics Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy BriaCell Therapeutics Corp. Stock?
BriaCell Therapeutics Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BriaCell Therapeutics Corp. Stock.

What's the current price of BriaCell Therapeutics Corp. Stock?
As of the end of day on the Jun 12, 2026, the price of an BriaCell Therapeutics Corp. (BCTX) share was $2.77.

What is the 52-week high and low for BriaCell Therapeutics Corp. Stock?
The 52-week high for BriaCell Therapeutics Corp. Stock is $14.68 and the 52-week low is $0.613.

What is the market capitalization of BriaCell Therapeutics Corp. Stock?
As of the Jun 12, 2026, the market capitalization of BriaCell Therapeutics Corp. is 5.218M.
Click to get the best stock tips daily for free!
ABOUT BRIACELL THERAPEUTICS CORP.
BriaCell Therapeutics
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immun...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE